Compounds > resveratrol
Page last updated: 2024-08-16

resveratrol and gemcitabine

resveratrol has been researched along with gemcitabine in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (8.33)29.6817
2010's9 (75.00)24.3611
2020's2 (16.67)2.80

Authors

AuthorsStudies
Beach, LB; Dapp, MJ; Heineman, RH; Mansky, LM; Martin, JL; Patterson, SE; Rawson, JM; Schnettler, EK1
Bonnac, L; Clouser, CL; Daly, MB; Kim, B; Landman, SR; Mansky, LM; Patterson, SE; Rawson, JM; Reilly, CS; Roth, ME; Xie, J1
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M1
Bodo, J; Duraj, J; Rauko, P; Sedlak, J; Sulikova, M1
Aggarwal, BB; Anand, P; Diagaradjane, P; Gelovani, J; Guha, S; Harikumar, KB; Krishnan, S; Kunnumakkara, AB; Pandey, MK; Sethi, G1
DeMorrow, S; Frampton, GA; Lazcano, EA; Li, H; Mohamad, A1
Chen, K; Chen, X; Duan, W; Gao, L; Jiang, Z; Lei, M; Ma, J; Ma, Q; Sun, L; Wang, Z; Zhou, C1
Bedel, A; Brillac, A; Buscail, E; Dabernat, S; de Verneuil, H; Moranvillier, I; Moreau-Gaudry, F; Peuchant, E; Rousseau, B; Vendrely, V1
Gurunathan, S; Peng, QL; Yuan, YG1
Cao, J; Chen, K; Cheng, L; Jiang, Z; Li, J; Ma, J; Ma, Q; Qian, W; Sha, H; Sun, L; Yan, B; Zhou, C1
Cao, J; Cheng, L; Duan, W; Jiang, Z; Li, J; Li, X; Ma, J; Ma, Q; Qian, W; Sun, L; Wang, F; Wu, E; Wu, Z; Yan, B; Zhou, C1
Li, J; Liu, J; Liu, Y; Qi, Z; Shen, Y; Tian, W; Yang, L; Yang, Y; Zhang, Q; Zhu, M1

Other Studies

12 other study(ies) available for resveratrol and gemcitabine

ArticleYear
5,6-Dihydro-5-aza-2'-deoxycytidine potentiates the anti-HIV-1 activity of ribonucleotide reductase inhibitors.
    Bioorganic & medicinal chemistry, 2013, Nov-15, Volume: 21, Issue:22

    Topics: Anti-HIV Agents; Cell Line, Tumor; Cell Survival; Deoxycytidine; Enzyme Inhibitors; Genes, Reporter; Green Fluorescent Proteins; HIV-1; Humans; Luminescent Proteins; Mutation; Red Fluorescent Protein; Resveratrol; Ribonucleotide Reductases; Stilbenes; Viral Proteins

2013
Synergistic reduction of HIV-1 infectivity by 5-azacytidine and inhibitors of ribonucleotide reductase.
    Bioorganic & medicinal chemistry, 2016, 06-01, Volume: 24, Issue:11

    Topics: Anti-HIV Agents; Azacitidine; Dose-Response Relationship, Drug; Enzyme Inhibitors; HIV Infections; HIV-1; Humans; Microbial Sensitivity Tests; Molecular Structure; Ribonucleotide Reductases; Structure-Activity Relationship

2016
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
    Disease models & mechanisms, 2023, 03-01, Volume: 16, Issue:3

    Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries

2023
Diverse resveratrol sensitization to apoptosis induced by anticancer drugs in sensitive and resistant leukemia cells.
    Neoplasma, 2006, Volume: 53, Issue:5

    Topics: Anticarcinogenic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Busulfan; Cell Cycle; Cell Line, Tumor; Cycloheximide; Deoxycytidine; Doxorubicin; Drug Resistance, Neoplasm; Flow Cytometry; Gemcitabine; Humans; Leukemia; Paclitaxel; Resveratrol; Stilbenes

2006
Resveratrol, a multitargeted agent, can enhance antitumor activity of gemcitabine in vitro and in orthotopic mouse model of human pancreatic cancer.
    International journal of cancer, 2010, Jul-15, Volume: 127, Issue:2

    Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Carcinoma, Pancreatic Ductal; Cell Cycle; Cell Proliferation; Cyclooxygenase 2; Deoxycytidine; Gemcitabine; Humans; Immunoenzyme Techniques; In Vitro Techniques; Male; Mice; Mice, Nude; NF-kappa B; Pancreatic Neoplasms; Resveratrol; Stilbenes; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays

2010
Resveratrol enhances the sensitivity of cholangiocarcinoma to chemotherapeutic agents.
    Laboratory investigation; a journal of technical methods and pathology, 2010, Volume: 90, Issue:9

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Proliferation; Cholangiocarcinoma; Cytochrome P-450 Enzyme System; Deoxycytidine; Fluorouracil; Gemcitabine; Mice; Mice, Nude; Mitomycin; Resveratrol; Stilbenes

2010
YAP Inhibition by Resveratrol via Activation of AMPK Enhances the Sensitivity of Pancreatic Cancer Cells to Gemcitabine.
    Nutrients, 2016, Sep-23, Volume: 8, Issue:10

    Topics: Adaptor Proteins, Signal Transducing; AMP-Activated Protein Kinases; Antineoplastic Agents; Cell Line, Tumor; Deoxycytidine; Enzyme Inhibitors; Gemcitabine; Gene Expression Regulation, Enzymologic; Humans; Pancreatic Neoplasms; Phosphoproteins; Resveratrol; RNA Interference; Signal Transduction; Stilbenes; Transcription Factors; YAP-Signaling Proteins

2016
Resveratrol and capsaicin used together as food complements reduce tumor growth and rescue full efficiency of low dose gemcitabine in a pancreatic cancer model.
    Cancer letters, 2017, 04-01, Volume: 390

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Capsaicin; Cell Cycle; Cell Line, Tumor; Deoxycytidine; Dose-Response Relationship, Drug; Gemcitabine; Humans; Mice; Mice, Nude; Pancreatic Neoplasms; Resveratrol; Signal Transduction; Stilbenes

2017
Silver nanoparticles enhance the apoptotic potential of gemcitabine in human ovarian cancer cells: combination therapy for effective cancer treatment.
    International journal of nanomedicine, 2017, Volume: 12

    Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Drug Delivery Systems; Female; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Metal Nanoparticles; Ovarian Neoplasms; Resveratrol; Silver; Stilbenes

2017
Resveratrol-Induced Downregulation of NAF-1 Enhances the Sensitivity of Pancreatic Cancer Cells to Gemcitabine via the ROS/Nrf2 Signaling Pathways.
    Oxidative medicine and cellular longevity, 2018, Volume: 2018

    Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Down-Regulation; Gemcitabine; Humans; Mitochondria; NF-E2-Related Factor 2; Pancreatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Reactive Oxygen Species; Resveratrol; Ribonucleoproteins; RNA Interference; RNA, Small Interfering; Signal Transduction; Stilbenes

2018
Resveratrol enhances the chemotherapeutic response and reverses the stemness induced by gemcitabine in pancreatic cancer cells via targeting SREBP1.
    Cell proliferation, 2019, Volume: 52, Issue:1

    Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Gemcitabine; Humans; Lipids; Mice; Mice, Transgenic; Neoplastic Stem Cells; Pancreas; Pancreatic Neoplasms; Resveratrol; RNA Interference; RNA, Small Interfering; Signal Transduction; Sterol Regulatory Element Binding Protein 1; Xenograft Model Antitumor Assays

2019
Gemcitabine potentiates anti-tumor effect of resveratrol on pancreatic cancer via down-regulation of VEGF-B.
    Journal of cancer research and clinical oncology, 2021, Volume: 147, Issue:1

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Biomarkers, Tumor; Cell Proliferation; Deoxycytidine; Drug Synergism; Female; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Pancreatic Neoplasms; Resveratrol; Tumor Cells, Cultured; Vascular Endothelial Growth Factor B; Xenograft Model Antitumor Assays

2021